MichaelThomasChinMD
Cardiology • Boston, MADean, Tufts Graduate School of Biomedical Sciences, Professor of Medicine, Director, MSTP Program, Research Director, Tufts Hypertrophic Cardiomyopathy Center and Research Institute
Dr. Chin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Washington St
Boston, MA 02111Phone+1 617-636-8066Fax+1 617-636-7175
Summary
- Dr. Michael Chin is a cardiologist based in Boston, MA, serving as the Research Director at Tufts Medical Center since 2017. He completed his fellowship in Cardiovascular Disease at Brigham and Women's Hospital and his residency in Internal Medicine at Johns Hopkins University. He graduated from the University of Rochester School of Medicine and Dentistry in 1991. Dr. Chin's clinical expertise encompasses general cardiology, hypertension, coronary artery disease, preventive cardiology, and lipid metabolism disorders. His recent publications, cited by peers, explore topics such as hypertrophic cardiomyopathy, Barth Syndrome, cardiomyopathy in mice, myocardial injury, and the role of proteins in cardiomyopathic disease.
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1994 - 1997
Johns Hopkins UniversityResidency, Internal Medicine, 1991 - 1993
University of Rochester School of Medicine and DentistryClass of 1991
Certifications & Licensure
MA State Medical License 1994 - 2026
NH State Medical License 2024 - 2024
ME State Medical License 2020 - 2021
WA State Medical License 2006 - 2019
MD State Medical License 1993 - 1994
Publications & Presentations
PubMed
- Single Cell Transcriptomic Profiling of-Associated Hypertrophic Cardiomyopathy Across Species Reveals Conservation of Biological Process But Not Gene Expression.Samia A Ali, Gayani Perera, Jason Laird, Rebecca Batorsky, Martin S Maron
Journal of the American Heart Association. 2025-01-07 - Cell-Penetrating Peptide Enhances Tafazzin Gene Therapy in Mouse Model of Barth Syndrome.Rahul Raghav, Junya Awata, Gregory L Martin, Douglas Strathdee, Robert M Blanton
International Journal of Molecular Sciences. 2024-12-18 - 1 citationsA Barth Syndrome Patient-DerivedPoint Mutation inDrives Progressive Cardiomyopathy in Mice.Paige L Snider, Elizabeth A Sierra Potchanant, Zejin Sun, Donna M Edwards, Ka-Kui Chan
International Journal of Molecular Sciences. 2024-07-27
Grant Support
- Project 4: Myocardial Inury And Apoptosis With DE ExposureNational Institute Of Environmental Health Sciences2008–2011
- Role Of Chf1/Hey2 In Hypertrophy And Heart FailureNational Heart, Lung, And Blood Institute2006–2009
- Role Of Chf1 In Occlusive Vascular DiseaseNational Heart, Lung, And Blood Institute2006–2008
- Role Of Chf1/Hey2 In Hypertrophy And Heart FailureNational Heart, Lung, And Blood Institute2006
- Role Of Chf1 In Occlusive Vascular DiseaseNational Heart, Lung, And Blood Institute2005–2006
- Role Of Chf1 In Cardiovascular DevelopmentNational Heart, Lung, And Blood Institute2001–2004
- HMG-I Y And ArteriosclerosisNational Heart, Lung, And Blood Institute1999–2001
- HMG-I Y And ArteriosclerosisNational Heart, Lung, And Blood Institute1997–1998
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
